Changes in Viral Load after Home-based HIV Testing and Counseling - Swaziland Naomi Bock 1, Ruth Emerson 2, Velephi Okello 3, Neena Philip 4, Deborah Donnell.

Slides:



Advertisements
Similar presentations
Add Governors Discretionary (1G) Grants Chapter 6.
Advertisements

MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
A Fractional Order (Proportional and Derivative) Motion Controller Design for A Class of Second-order Systems Center for Self-Organizing Intelligent.
TCCI Barometer September “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
Before Between After.
Quality Improvement Team
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
Feasibility and acceptability of an antiretroviral treatment as prevention (TasP) intervention in rural South Africa Results from the ANRS TasP cluster-randomised.
Male Circumcision in Swaziland: Demographics, Behaviors and HIV Prevalence Findings from the Swaziland HIV Incidence Measurement Survey (SHIMS) Abstract#
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Late HIV Diagnoses, Georgia,
Virologic and immunologic response following antiretroviral therapy initiation among pregnant and postpartum women with acute HIV-1 infection: MOPDB0101.
Illustrating the HIV Care Continuum in U.S. Cities
Estimating National HIV Incidence from Directly Observed Seroconversions in the Swaziland HIV Incidence Measurement Survey Jason Reed, Jessica Justman,
HIV Care Continuum for the United States and Puerto Rico National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
1 Using Biostatistics to Evaluate Vaccines and Medical Tests Holly Janes Fred Hutchinson Cancer Research Center.
Illustrating the HIV Care Continuum in U.S. Cities Chicago, IL.
Illustrating the HIV Care Continuum in U.S. Cities Atlanta, GA.
Illustrating the HIV Care Continuum in U.S. Cities Philadelphia, PA.
Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.
Monitoring Indicators of the National HIV/AIDS Strategy Using Data for Public Health Action Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
Measuring the burden of undiagnosed HIV infection from a population-based survey in Bukoba, Tanzania: merits of a home-based testing approach Haruka Maruyama.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
Link4Health Study: A combination strategy for linkage to and retention in HIV care in Swaziland Margaret L. McNairy, Matthew R. Lamb, Averie B. Gachuhi,
Findings from the 2016 Zambia Population-based HIV Impact Assessment (ZAMPHIA): HIV prevalence, incidence and progress towards the goals Danielle.
Correlates of being outside the cascade among adults aged years in Zimbabwe: Results from the Zimbabwe Population-based HIV.
Center for Studies of Addiction, University of Pennsylvania, USA
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
Prepared by NGO “Baltic HIV Association” Sources: ECDC/WHO Euro, EuroHIV, Centre for Disease Prevention and Control of Latvia.
Illustrating the HIV Care Continuum in U.S. Cities
Illustrating the HIV Care Continuum in U.S. Cities
Conclusions & Implications
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
Conclusions Background Results Acknowledgements: Methods
First roll out of universal access to antiretroviral therapy under routine program conditions in rural Swaziland. Authors: Bernhard Kerschberger (1), Sikhathele.
Illustrating the HIV Care Continuum in U.S. Cities
Illustrating the HIV Care Continuum in U.S. Cities
People living with AIDS in Maine at the end of 1984
Vaccine and Infectious Disease Institute
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Prevention of mother to child transmission and early infant diagnosis in Malawi: Accomplishments of a mature Option B+ program in a resource-limited setting.
Illustrating the HIV Care Continuum in U.S. Cities
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Performing Sedia Asante: Testing algorithm
Summary Sheet Figures and Maps
Performing Maxim Swift RIA: Testing algorithm
Rose Nyirenda Ministry of Health, Malawi
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
HIV Recency Testing in Rwanda
Presentation transcript:

Changes in Viral Load after Home-based HIV Testing and Counseling - Swaziland Naomi Bock 1, Ruth Emerson 2, Velephi Okello 3, Neena Philip 4, Deborah Donnell 2, George Bicego 1, Peter Ehrenkranz 1, Rejoice Nkambule 3, Azih Charles Ikechi 3, Yen Duong 1, Jessica Justman 4 1 Centers for Disease Control and Prevention, Atlanta, USA and Mbabane, Swaziland, 2 Statistical Center for HIV/AIDS Research and Prevention and the Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, USA, 3 Ministry of Health, Swaziland, 4 ICAP-Columbia, Mailman School of Public Health, Columbia University, New York, USA

Participated 18,172 (74%) HIV+ 5,803 (32%) HIV-Neg 12,367 (68%) Selected for sub-group return visit 8-12 months after baseline FU 1,067 (15%) No contact/Refused 6384 (26%) Total potential participants in 2011: 24, 556 Viral load at baseline and FU; & CD4 at FU 922 (86%) 2 Random sample of adults who tested HIV+ at HBHTC as part of SHIMS underwent repeat viral load testing 8-12 months later

Total N VL < 1000 Baseline: (%) VL < 1000 at FU: (%) Change TOTAL 92241%47%7% HIV Aware at Baseline 65454%60%6% ART use at baseline 37286%85%-1% Initiated ART between baseline and FU 6018%78%60% No ART use 2239%12%3% Unaware at Baseline (newly diagnosed) 2687%15%8% Initiated ART between baseline and FU 3910%67%57% No reported ART use 2297%6%-1% Change in proportion with VL suppression by HIV awareness and by ART use at baseline and follow-up of 922 adults

Total N VL < 1000 Baseline: (%) VL < 1000 at FU: (%) Change TOTAL 92241%47%7% HIV Aware at Baseline 65454%60%6% ART use at baseline 37286%85%-1% Initiated ART between baseline and FU 6018%78%60% No ART use 2239%12%3% Unaware at Baseline (newly diagnosed) 2687%15%8% Initiated ART between baseline and FU 3910%67%57% No reported ART use 2297%6%-1% Change in proportion with VL suppression by HIV awareness and by ART use at baseline and follow-up of 922 adults

Total N VL < 1000 Baseline: (%) VL < 1000 at FU: (%) Change TOTAL 92241%47%7% HIV Aware at Baseline 65454%60%6% ART use at baseline 37286%85%-1% Initiated ART between baseline and FU 6018%78%60% No ART use 2239%12%3% Unaware at Baseline (newly diagnosed) 2687%15%8% Initiated ART between baseline and FU 3910%67%57% No reported ART use 2297%6%-1% Change in proportion with VL suppression by HIV awareness and by ART use at baseline and follow-up of 922 adults

Total N VL < 1000 Baseline: (%) VL < 1000 at FU: (%) Change TOTAL 92241%47%7% HIV Aware at Baseline 65454%60%6% ART use at baseline 37286%85%-1% Initiated ART between baseline and FU 6018%78%60% No ART use 2239%12%3% Unaware at Baseline (newly diagnosed) 2687%15%8% Initiated ART between baseline and FU 3910%67%57% No reported ART use 2297%6%-1% Change in proportion with VL suppression by HIV awareness and by ART use at baseline and follow-up of 922 adults

Total N VL < 1000 Baseline: (%) VL < 1000 at FU: (%) Change TOTAL 92241%47%7% HIV Aware at Baseline 65454%60%6% ART use at baseline 37286%85%-1% Initiated ART between baseline and FU 6018%78%60% No ART use 2239%12%3% Unaware at Baseline (newly diagnosed) 2687%15%8% Initiated ART between baseline and FU 3910%67%57% No reported ART use 2297%6%-1% Change in proportion with VL suppression by HIV awareness and by ART use at baseline and follow-up of 922 adults

Total N VL < 1000 Baseline: (%) VL < 1000 at FU: (%) Change TOTAL 92241%47%7% HIV Aware at Baseline 65454%60%6% ART use at baseline 37286%85%-1% Initiated ART between baseline and FU 6018%78%60% No reported ART use 2239%12%3% Unaware at Baseline (newly diagnosed) 2687%15%8% Initiated ART between baseline and FU 3910%67%57% No reported ART use 2297%6%-1% Change in proportion with VL suppression by HIV awareness and by ART use at baseline and follow-up of 922 adults

Conclusions  HBHTC increased knowledge of HIV-infected status and the proportion of those on ART in the study population.  Although VL suppression was high among those on ART, including among those who had started between baseline and follow up, the overall increase in proportion with viral suppression was small, from 40 to 47%.  The results of this study indicate that stronger linkage interventions and broader ART eligibility criteria are necessary to realize the potential of HBHTC for lowering population VL.